NITI Aayog chooses CCMB to house Atal Incubation Centre

It’s one among the 10 institutions in India selected for the facility

June 22, 2017 11:56 pm | Updated 11:56 pm IST - HYDERABAD

Niti-Aayog has chosen the Centre for Cellular and Molecular Biology (CCMB) here for hosting the ₹10-crore Atal Incubation Centre aimed at identifying promising start-ups, creating facilities and guiding them to success in the field of biotechnology.

The CCMB, a constituent laboratory of Council of Scientific and Industrial Research (CSIR), is among the 10 institutions across the country to be chosen for the facility and the only one in the Telugu States of Telangana and Andhra Pradesh, said Director Rakesh K. Mishra at a press conference here on Thursday.

About 3,800 government and private institutions were vying to host the incubation centre with 230 applying from within Telangana alone, but CCMB got the nod and the new facility would come up on its campus at Uppal, said Dr. Mishra.

Promoting innovation

The Central government has set up the Atal Innovation Mission (AIM) under NITI Aayog for promoting a culture of innovation and entrepreneurship in the country as it felt the need for creating high-class incubation facilities with necessary infrastructure, he said.

NITI Aayog’s support through the Mission would help catalyse the efforts of the start-ups in biotechnology to scale up as successful entrepreneurs, he said. Upcoming firms would also be engaged with issues like intellectual property agencies, regulators, seed funders, business developers, research institutions etc.

The ongoing skill training programmes, research strength of the centre, biotechnology industry’s maturity here and the Telangana government’s support would serve as an ideal platform to take entrepreneurship in biotechnology to the next level, Dr. Mishra observed.

His colleague N. Madhusudhan Rao said there was a lot of activity on developing point of care devices for various human and non-human diseases, to capture the shifting therapy from drugs to biologics, to engage in big data analysis for precision medicine and in the area of stem cell therapies.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.